Overseas Pharmaceuticals, Ltd.

About Us

Specializing in oral solid sustained-release technology, sustained-release new drugs, and related fields.

A leading Controlled Release DDS company with a focus to enhance the value of your existing assets (LCM) by offering superior efficacy and safety profiles, convenient to use, extended IP protection, and combination products.
12 years product development effort resulted in rich post-POC pipelines for your fast commercialization.
About 200 Subject-Matter-Experts and Scientists globally to help fulfill your unmet needs.

Core Team Members

Dr.Gilbert

Wen-Founder and Chairman

Dr.Gilbert Wen-Founder and Chairman

Dr.Zhi Liu

Chief R&D Consultant

Dr.Danchen Gao

Global SVP of Corporate Strategy

Dr.Huaihan Cai

Director,Medical Affairs

Dr.Huaihan Cai-Director,Medical Affairs

Dr.Shuo Zhang

Director,Formulation R&D

Dr.Shuo Zhang-Director,Formulation R&D

Dr.Maggie Lu

Director,Clinical Pharmacology

Dr.Maggie Lu-Director,Clinical Pharmacology

Dr.Gilbert Wen

Founder/Chairman

Dr.Zhi Liu

Chief R&D Consultant

Dr.Danchen Gao

Global SVP of Corporate Strategy

Dr.Huaihan Cai

Director, Medical Affairs

Dr.Shuo Zhang

Director,Formulation R&D

Dr.Maggie Lu

Director, Clinical Pharmacology

Product

US FDA Approved Product: Levetiracetam Extended Release Tablet has been approved by US FDA

US FDA Accepted Application for Approval: Lamotrigine Extended Release has been accepted by US FDA for review

NDA batch manufacture: Ibuprofen Bilayer Tablet has been conducted

Approval of clinical trials: 12 INDs (Investigational New Drug) have been granted by US FDA for clinical trials

Pilot PK studies: 21 human pilot PK studies have been conducted

Animal PK studies: 14 animal studies have been conducted for new drug candidates

Development Timeline

About us: Introduction; Core Team

Technology

Product: Product Development Status; Clinical Trials Approval; Development Timeline

Capability: Equipment; Apparatus; Facilities

Collaboration: Visit to Clinical Sites; Collaboration Partners

Contact

Address：Suite 201, Building C1, #11 Kaiyuan Avenue, Huangpu District, Guangzhou City,                   Guangdong Province, P.R.China 510700
                  Building G106 Phase 5, China Medical City, HIGH-TECH Zone, Taizhou City, Jiangsu                   Province,P.R.225300
                  6323 Nancy ridge Drive San Diego California USA 92121

Tel：+86-20-31600402（Guangzhou）
+86-523-86813669（Taizhou）
+1-(650)3889210（USA）

E-mail：contact@overseaspharm.com